Sildenafil 25 MG Oral Film — RxCUI 2735822
RxNorm drug concept · Semantic clinical drug
RxCUI 2735822
Semantic clinical drug · SCD
● Current RxNorm concept 8 FDA products
31 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2735822
Official nameSildenafil 25 MG Oral Film
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assildenafil (as sildenafil citrate) 25 MG Oral Film
FDA products mapped8
Package NDCs mapped31
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Sildenafil: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- For erectile dysfunction, you take sildenafil only when you need it — about 30 minutes to 1 hour before sexual activity works best, though anywhere from 30 minutes to 4 hours ahead...
- Can I take Viagra or generic sildenafil just before sex, or do I need to take it every day?
- Both sildenafil and nitrates lower blood pressure, and together their effect on blood pressure can be dangerously large — we're talking about a drop severe enough to cause fainting...
- Why can't I take sildenafil with nitroglycerin or other nitrate medicines?
🕸️ Concept Web — How Sildenafil 25 MG Oral Film Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Sildenafil 25 MG Oral Film
RxCUI 2735822 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Sildenafil
136411IN
-
Sildenafil
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Vybrique
2735816BN
-
Vybrique
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Sildenafil Oral Film
2735814SCDF -
Sildenafil Oral Film Product
2735813SCDG -
Sildenafil Oral Product
1159091SCDG -
Sildenafil Oral Film [Vybrique]
2735820SBDF -
Vybrique Oral Film Product
2735819SBDG -
Vybrique Oral Product
2735818SBDG -
Oral Film
2269575DF -
Oral Film Product
2269502DFG - +1 more in this family
-
Sildenafil Oral Film
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Sildenafil 25 MG
258300SCDC -
Sildenafil 25 MG Oral Film [Vybrique]
2735824SBD -
Sildenafil 25 MG [Vybrique]
2735823SBDC
-
Sildenafil 25 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Sildenafil 25 MG
SCDC · 258300 -
Sildenafil Oral Film
SCDF · 2735814 -
Sildenafil Oral Film Product
SCDG · 2735813 -
Sildenafil Oral Product
SCDG · 1159091
Brand-Name Concepts
-
Sildenafil 25 MG Oral Film [Vybrique]
SBD · 2735824 -
Sildenafil 25 MG [Vybrique]
SBDC · 2735823 -
Sildenafil Oral Film [Vybrique]
SBDF · 2735820 -
Vybrique Oral Film Product
SBDG · 2735819 -
Vybrique Oral Product
SBDG · 2735818 -
Vybrique
BN · 2735816
📦 FDA Products & Package NDCs
8 products · 31 package NDCs
31 package NDCs map to RxCUI 2735822 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 71858-0205-02 | 1 FILM in 1 POUCH (71858-0205-2) | Vybrique | IBSA Pharma Inc. | 2026-02-15 |
| 71858-0205-04 | 1 FILM in 1 POUCH (71858-0205-4) | Vybrique | IBSA Pharma Inc. | 2026-02-15 |
| 71858-0205-05 | 4 POUCH in 1 CARTON (71858-0205-5) / 1 FILM in 1 POUCH | Vybrique | IBSA Pharma Inc. | 2026-02-15 |
| 71858-0205-06 | 8 POUCH in 1 CARTON (71858-0205-6) / 1 FILM in 1 POUCH | Vybrique | IBSA Pharma Inc. | 2026-02-15 |
| 71858-0210-01 | 2 POUCH in 1 CARTON (71858-0210-1) / 1 FILM in 1 POUCH | Vybrique | IBSA Pharma Inc. | 2026-02-15 |
| 71858-0210-02 | 1 FILM in 1 POUCH (71858-0210-2) | Vybrique | IBSA Pharma Inc. | 2026-02-15 |
| 71858-0210-04 | 1 FILM in 1 POUCH (71858-0210-4) | Vybrique | IBSA Pharma Inc. | 2026-02-15 |
| 71858-0210-05 | 4 POUCH in 1 CARTON (71858-0210-5) / 1 FILM in 1 POUCH | Vybrique | IBSA Pharma Inc. | 2026-02-15 |
| 71858-0210-06 | 8 POUCH in 1 CARTON (71858-0210-6) / 1 FILM in 1 POUCH | Vybrique | IBSA Pharma Inc. | 2026-02-15 |
| 71858-0215-01 | 2 POUCH in 1 CARTON (71858-0215-1) / 1 FILM in 1 POUCH | Vybrique | IBSA Pharma Inc. | 2026-02-15 |
| 71858-0215-02 | 1 FILM in 1 POUCH (71858-0215-2) | Vybrique | IBSA Pharma Inc. | 2026-02-15 |
| 71858-0215-04 | 1 FILM in 1 POUCH (71858-0215-4) | Vybrique | IBSA Pharma Inc. | 2026-02-15 |
| 71858-0215-05 | 4 POUCH in 1 CARTON (71858-0215-5) / 1 FILM in 1 POUCH | Vybrique | IBSA Pharma Inc. | 2026-02-15 |
| 71858-0215-06 | 8 POUCH in 1 CARTON (71858-0215-6) / 1 FILM in 1 POUCH | Vybrique | IBSA Pharma Inc. | 2026-02-15 |
| 71858-0220-01 | 2 POUCH in 1 CARTON (71858-0220-1) / 1 FILM in 1 POUCH | Vybrique | IBSA Pharma Inc. | 2026-02-15 |
| 71858-0220-02 | 1 FILM in 1 POUCH (71858-0220-2) | Vybrique | IBSA Pharma Inc. | 2026-02-15 |
| 71858-0220-04 | 1 FILM in 1 POUCH (71858-0220-4) | Vybrique | IBSA Pharma Inc. | 2026-02-15 |
| 71858-0220-05 | 4 POUCH in 1 CARTON (71858-0220-5) / 1 FILM in 1 POUCH | Vybrique | IBSA Pharma Inc. | 2026-02-15 |
| 71858-0220-06 | 8 POUCH in 1 CARTON (71858-0220-6) / 1 FILM in 1 POUCH | Vybrique | IBSA Pharma Inc. | 2026-02-15 |
| 82347-0205-04 | 1 FILM in 1 POUCH (82347-0205-4) | Sildenafil | Yaral Pharma Inc. | 2026-02-15 |
| 82347-0205-05 | 4 POUCH in 1 CARTON (82347-0205-5) / 1 FILM in 1 POUCH | Sildenafil | Yaral Pharma Inc. | 2026-02-15 |
| 82347-0205-06 | 8 POUCH in 1 CARTON (82347-0205-6) / 1 FILM in 1 POUCH | Sildenafil | Yaral Pharma Inc. | 2026-02-15 |
| 82347-0210-04 | 1 FILM in 1 POUCH (82347-0210-4) | Sildenafil | Yaral Pharma Inc. | 2026-02-15 |
| 82347-0210-05 | 4 POUCH in 1 CARTON (82347-0210-5) / 1 FILM in 1 POUCH | Sildenafil | Yaral Pharma Inc. | 2026-02-15 |
| 82347-0210-06 | 8 POUCH in 1 CARTON (82347-0210-6) / 1 FILM in 1 POUCH | Sildenafil | Yaral Pharma Inc. | 2026-02-15 |
| 82347-0215-04 | 1 FILM in 1 POUCH (82347-0215-4) | Sildenafil | Yaral Pharma Inc. | 2026-02-15 |
| 82347-0215-05 | 4 POUCH in 1 CARTON (82347-0215-5) / 1 FILM in 1 POUCH | Sildenafil | Yaral Pharma Inc. | 2026-02-15 |
| 82347-0215-06 | 8 POUCH in 1 CARTON (82347-0215-6) / 1 FILM in 1 POUCH | Sildenafil | Yaral Pharma Inc. | 2026-02-15 |
| 82347-0220-04 | 1 FILM in 1 POUCH (82347-0220-4) | Sildenafil | Yaral Pharma Inc. | 2026-02-15 |
| 82347-0220-05 | 4 POUCH in 1 CARTON (82347-0220-5) / 1 FILM in 1 POUCH | Sildenafil | Yaral Pharma Inc. | 2026-02-15 |
| 82347-0220-06 | 8 POUCH in 1 CARTON (82347-0220-6) / 1 FILM in 1 POUCH | Sildenafil | Yaral Pharma Inc. | 2026-02-15 |
Observed labelers:
IBSA Pharma Inc. (19) ·
Yaral Pharma Inc. (12)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.